Federal Register / Vol. 62, No. 228 / Wednesday, November 26, 1997 / Notices 63181

acquire voting shares of Farmers State

Bankshares, Inc., Cheyenne, Wyoming,

and thereby indirectly acquire Wyoming

Bank & Trust, Cheyenne, Wyoming.

Board of Governors of the Federal Reserve

System, November 20, 1997.

Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 97–30967 Filed 11–25–97; 8:45 am]

BILLING CODE 6210–01–F

FEDERAL RESERVE SYSTEM

Sunshine Act Meeting

AGENCY HOLDING THE MEETING: Board of

Governors of the Federal Reserve

System.

TIME AND DATE: 11:00 a.m., Monday,

December 1, 1997.

PLACE: Marriner S. Eccles Federal

Reserve Board Building, 20th and C

Streets, N.W., Washington, D.C. 20551.

STATUS: Closed.

MATTERS TO BE CONSIDERED:

1. Personnel actions (appointments,

promotions, assignments,

reassignments, and salary actions)

involving individual Federal Reserve

System employees.

2. Any items carried forward from a

previously announced meeting.

CONTACT PERSON FOR MORE INFORMATION:

Joseph R. Coyne, Assistant to the Board;

202–452–3204.

SUPPLEMENTARY INFORMATION: You may

call 202–452–3206 beginning at

approximately 5 p.m. two business days

before the meeting for a recorded

announcement of bank and bank

holding company applications

scheduled for the meeting; or you may

contact the Board’s Web site at http://

www.bog.frb.fed.us for an electronic

announcement that not only lists

applications, but also indicates

procedural and other information about

the meeting.

Dated: November 21, 1997.

Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 97–31151 Filed 11–21–97; 4:09 pm]

BILLING CODE 6210–01–P

GENERAL SERVICES

ADMINISTRATION

Performance Review Board;

Membership; Senior Executive Service

AGENCY: General Services

Administration.

ACTION: Notice.

SUMMARY: Notice is hereby given of the

names of the members of the

Performance Review Board.

FOR FURTHER INFORMATION CONTACT:

Gail T. Lovelace, Director of Human

Resources, General Services

Administration, 1800 F Street, N.W.,

Washington, DC 20405, (202) 501–0398.

SUPPLEMENTARY INFORMATION: Section

4313(c) (1) through (5) of Title 5 U.S.C.

requires each agency to establish in

accordance with regulations prescribed

by the Office of Personnel Management,

one or more Performance Review

Board(s). The Board(s) shall review the

performance rating of each senior

executive’s performance by the

supervisor, along with any

recommendation to the appointing

authority relative to the performance of

the senior executive.

Members of the Review Board are:

1. Thurman M. Davis, Sr.

(Chairperson), Deputy Administrator.

2. Martha N. Johnson, Chief of Staff.

3. Dennis J. Fisher, Commissioner,

Federal Technology Service.

4. Robert A. Peck, Commissioner,

Public Buildings Service.

5. Frank P. Pugliese, Commissioner,

Federal Supply Service.

6. G. Martin Wagner, Associate

Administrator for Governmentwide

Policy.

Dated: November 20, 1997.

Gail T. Lovelace,

Director of Human Resources.

[FR Doc. 97–31038 Filed 11–25–97; 8:45 am]

BILLING CODE 6820–BR–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

[Docket No. 97N–0472]

Agency Information Collection

Activities: Proposed Collection;

Comment Request

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing an

opportunity for public comment on the

proposed collection of certain

information by the agency. Under the

Paperwork Reduction Act of 1995 (the

PRA), Federal agencies are required to

publish notice in the Federal Register

concerning each proposed collection of

information, including each

reinstatement of an existing collection

of information, and to allow 60 days for

public comment in response to the

notice. This notice solicits comments on

requirements for filing a petition for

administrative stay of action.

DATES: Submit written comments on the

collection of information by January 26,

1998.

ADDRESSES: Submit written comments

on the collection of information to the

Dockets Management Branch (HFA–

305), Food and Drug Administration,

12420 Parklawn Dr., rm. 1–23,

Rockville, MD 20857. All comments

should be identified with the docket

number found in brackets in the

heading of this document.

FOR FURTHER INFORMATION CONTACT:

JonnaLynn P. Capezzuto, Office of

Information Resources Management

(HFA–250), Food and Drug

Administration, 5600 Fishers Lane, rm.

16B–19, Rockville, MD 20857, 301–827–

4659.

SUPPLEMENTARY INFORMATION: Under the

PRA (44 U.S.C. 3501–3520), Federal

agencies must obtain approval from the

Office of Management and Budget

(OMB) for each collection of

information they conduct or sponsor.

‘‘Collection of information’’ is defined

in 44 U.S.C. 3502 (3) and 5 CFR 1320.3

(c) and includes agency requests or

requirements that members of the public

submit reports, keep records, or provide

information to a third party. Section

3506 (c) (2) (A) of the PRA (44 U.S.C.

3506 (c) (2) (A)) requires Federal

agencies to provide a 60-day notice in

the Federal Register concerning each

proposed collection of information,

including each proposed reinstatement

of an existing collection of information,

before submitting the collection to OMB

for approval. To comply with this

requirement, FDA is publishing notice

of the proposed collection of

information listed below.

With respect to the following

collection of information, FDA invites

comments on: (1) Whether the proposed

collection of information is necessary

for the proper performance of FDA’s

functions, including whether the

information will have practical utility;

(2) the accuracy of FDA’s estimate of the

burden of the proposed collection of

information, including the validity of

the methodology and assumptions used;

(3) ways to enhance the quality, utility,

and clarity of the information to be

collected; and (4) ways to minimize the

burden of the collection of information

on respondents, including through the

use of automated collection techniques,

when appropriate, and other forms of

information technology.
63182 Federal Register / Vol. 62, No. 228 / Wednesday, November 26, 1997 / Notices

Petition For Administrative Stay of

Action—21 CFR Part 10.35 (OMB

Control Number 0910—0194)—

Reinstatement

Section 10.35 (21 CFR 10.35), issued

under the authority of section 701(a) of

the Federal Food, Drug, and Cosmetic

Act (21 U.S.C. 371(a)), sets forth the

format and procedures by which an

interested person may file a petition for

an administrative stay of action.

Respondents to this information

collection are interested persons who

choose to file a petition for an

administrative stay of action. Such a

petition must: (1) Identify the decision

involved; (2) state the action

requested—including the length of time

for which a stay is requested; and (3)

include a statement of the factual and

legal grounds on which the interested

person relies in seeking the stay. The

information provided in the petition is

used by the agency to determine

whether the requested stay should be

granted.

FDA estimates the burden of this

collection of information as follows:

TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1

21 CFR Section No. of

Respondents

Annual

Frequency per

Response

Total Annual

Responses

Hours per

Response Total Hours

10.35 7 1 7 100 700

1There are no capital costs or operating and maintenance costs associated with this collection of information.

The burden estimate for this

collection of information is based on

FDA’s experience with petitions for

administrative stay of action over the

past 3 years. Agency personnel

responsible for processing the filing of

petitions for administrative stays of

action estimate that seven such petitions

are received by the agency annually,

with each requiring approximately 100

hours of preparation time.

Dated: November 19, 1997

William K. Hubbard,

Associate Commissioner for Policy

Coordination.

[FR Doc. 97–30982 Filed 11–25–97; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

[Docket No. 91N–0396]

Agency Information Collection

Activities; Submission for OMB

Review; Comment Request

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

that the proposed collection of

information listed below has been

submitted to the Office of Management

and Budget (OMB) for review and

clearance under the Paperwork

Reduction Act of 1995 (the PRA).

DATES: Submit written comments on the

collection of information by December

26, 1997.

ADDRESSES: Submit written comments

on the collection of information to the

Office of Information and Regulatory

Affairs, OMB, New Executive Office

Bldg., 725 17th St. NW., rm. 10235,

Washington, DC 20503, Attn: Desk

Officer for FDA.

FOR FURTHER INFORMATION CONTACT:

Margaret R. Schlosburg, Office of

Information Resources Management

(HFA–250), Food and Drug

Administration, 5600 Fishers Lane,

Rockville, MD 20857, 301–827–1223.

SUPPLEMENTARY INFORMATION: In

compliance with section 3507 of the

PRA (44 U.S.C. 3507), FDA has

submitted the following proposed

collection of information to OMB for

review and clearance.

Reports of Corrections and Removals

for Manufacturers, Importers, and

Distributors of Medical Devices (21 CFR

806.10 and 806.20).

In a final rule published in the

Federal Register of May 19, 1997 (62 FR

27183), FDA issued regulations

requiring that manufacturers, importers,

and distributors of medical devices

report promptly to FDA any corrections

or removals of a device undertaken to

reduce a risk to health posed by the

device or to remedy a violation of the

Federal Food, Drug, and Cosmetic Act

(the act) that could present a risk to

health. The collection of this

information is required by section 519(f)

of the act (21 U.S.C. 360i(f)). These

regulations will help FDA to protect the

public health by ensuring that the

agency has current and complete

information regarding those actions

taken to reduce risks to health caused by

devices. Reports of such actions will

improve the agency’s ability to evaluate

device-related problems and to take

prompt action against potentially

dangerous devices.

TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN

21 CFR Section No. of

Respondents

Annual

Frequency per

Response

Total Annual

Responses

Hours per

Response Total Hours

806.10 880 1 880 10 8,800

TABLE 2.—ESTIMATED ANNUAL RECORDKEEPING BURDEN1

21 CFR Section No. of

Recordkeepers

Annual

Frequency per

Recordkeeping

Total Annual

Records

Hours per

Recordkeeper Total Hours

806.20 440 1 440 10 4,400

1There are no capital costs or operating and maintenance costs associated with this collection of information.